← Every applicant
Difgen Pharms FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| EPINEPHRINENew drugSep 15, 2026SOLUTION, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| LIDOCAINENew drugMar 25, 2025PATCH, TOPICAL |
| BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDENew drugJun 2, 2022FILM, BUCCAL, SUBLINGUAL |
| BUPRENORPHINENew drugSep 23, 2021FILM, EXTENDED RELEASE, TRANSDERMAL |